Nanosonics Crecimiento futuro
Future controles de criterios 4/6
Nanosonics se prevé un crecimiento anual de los beneficios y los ingresos de 20.9% y 9.3% respectivamente. Se prevé que el BPA sea de grow en 20.2% al año. Se prevé que la rentabilidad de los fondos propios sea de 11% en 3 años.
Información clave
24.0%
Tasa de crecimiento de los beneficios
23.7%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 16.9% |
| Tasa de crecimiento de los ingresos | 10.1% |
| Rentabilidad financiera futura | 12.5% |
| Cobertura de analistas | Good |
| Última actualización | 05 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Returns On Capital At Nanosonics (ASX:NAN) Paint A Concerning Picture
Feb 27
Some Confidence Is Lacking In Nanosonics Limited (ASX:NAN) As Shares Slide 33%
Jan 24Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Nov 08Investors Will Want Nanosonics' (ASX:NAN) Growth In ROCE To Persist
Oct 04Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Jul 12Nanosonics (ASX:NAN) Will Be Hoping To Turn Its Returns On Capital Around
May 16Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 09This Is Why Nanosonics Limited's (ASX:NAN) CEO Compensation Looks Appropriate
Nov 11A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Oct 28What Does Nanosonics Limited's (ASX:NAN) Share Price Indicate?
Oct 06A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Jul 18At AU$3.36, Is Nanosonics Limited (ASX:NAN) Worth Looking At Closely?
Jun 26Nanosonics (ASX:NAN) Will Want To Turn Around Its Return Trends
Jun 07A Look At The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Mar 08Nanosonics Limited (ASX:NAN) Analysts Just Cut Their EPS Forecasts
Feb 15Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 02Nanosonics Limited's (ASX:NAN) CEO Looks Due For A Compensation Raise
Nov 12Returns Are Gaining Momentum At Nanosonics (ASX:NAN)
Aug 03An Intrinsic Calculation For Nanosonics Limited (ASX:NAN) Suggests It's 21% Undervalued
Mar 30Returns On Capital - An Important Metric For Nanosonics (ASX:NAN)
Mar 15Time To Worry? Analysts Are Downgrading Their Nanosonics Limited (ASX:NAN) Outlook
Feb 28Nanosonics Limited's (ASX:NAN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 19Is There Now An Opportunity In Nanosonics Limited (ASX:NAN)?
Feb 07What Did Nanosonics' (ASX:NAN) CEO Take Home Last Year?
Jan 26How Much Of Nanosonics Limited (ASX:NAN) Do Insiders Own?
Jan 14Here's Why Nanosonics's (ASX:NAN) Statutory Earnings Are Arguably Too Conservative
Jan 01Estimating The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Dec 20Is There More Growth In Store For Nanosonics' (ASX:NAN) Returns On Capital?
Dec 07Can You Imagine How Elated Nanosonics' (ASX:NAN) Shareholders Feel About Its 302% Share Price Gain?
Nov 25Is Nanosonics' (ASX:NAN) Share Price Gain Of 250% Well Earned?
Jul 28Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 6/30/2026 | 208 | 19 | 20 | 26 | 10 |
| 6/30/2025 | 192 | 14 | 12 | 17 | 12 |
| 6/30/2024 | 167 | 9 | 15 | 18 | 12 |
| 12/31/2023 | 164 | 16 | 22 | 24 | N/A |
| 9/30/2023 | 165 | 18 | 21 | 24 | N/A |
| 6/30/2023 | 166 | 20 | 20 | 23 | N/A |
| 3/31/2023 | 154 | 15 | 15 | 20 | N/A |
| 12/31/2022 | 141 | 10 | 10 | 16 | N/A |
| 9/30/2022 | 131 | 7 | 5 | 11 | N/A |
| 6/30/2022 | 120 | 4 | 0 | 7 | N/A |
| 3/31/2022 | 120 | 7 | 2 | 7 | N/A |
| 12/31/2021 | 121 | 11 | 4 | 8 | N/A |
| 9/30/2021 | 112 | 10 | 5 | 8 | N/A |
| 6/30/2021 | 103 | 9 | 6 | 7 | N/A |
| 3/31/2021 | 99 | 7 | 7 | 9 | N/A |
| 12/31/2020 | 95 | 6 | 8 | 10 | N/A |
| 9/30/2020 | 97 | 8 | 15 | 16 | N/A |
| 6/30/2020 | 100 | 10 | 21 | 23 | N/A |
| 3/31/2020 | 96 | 11 | 16 | 18 | N/A |
| 12/31/2019 | 92 | 12 | 11 | 13 | N/A |
| 9/30/2019 | 88 | 13 | 7 | 9 | N/A |
| 6/30/2019 | 84 | 14 | 3 | 5 | N/A |
| 3/31/2019 | 78 | 12 | 3 | 6 | N/A |
| 12/31/2018 | 71 | 11 | 4 | 6 | N/A |
| 9/30/2018 | 66 | 8 | 5 | 8 | N/A |
| 6/30/2018 | 61 | 6 | 6 | 9 | N/A |
| 3/31/2018 | 61 | 6 | 8 | 11 | N/A |
| 12/31/2017 | 61 | 6 | 11 | 13 | N/A |
| 9/30/2017 | 64 | 16 | N/A | 15 | N/A |
| 6/30/2017 | 68 | 26 | N/A | 16 | N/A |
| 3/31/2017 | 65 | 26 | N/A | 16 | N/A |
| 12/31/2016 | 63 | 25 | N/A | 16 | N/A |
| 9/30/2016 | 53 | 13 | N/A | 10 | N/A |
| 6/30/2016 | 43 | 0 | N/A | 3 | N/A |
| 3/31/2016 | 33 | -5 | N/A | -3 | N/A |
| 12/31/2015 | 23 | -10 | N/A | -8 | N/A |
| 9/30/2015 | 23 | -8 | N/A | -5 | N/A |
| 6/30/2015 | 22 | -5 | N/A | -2 | N/A |
| 3/31/2015 | 24 | -2 | N/A | 0 | N/A |
| 12/31/2014 | 26 | 2 | N/A | 2 | N/A |
| 9/30/2014 | 24 | 0 | N/A | 0 | N/A |
| 6/30/2014 | 21 | -3 | N/A | -3 | N/A |
| 3/31/2014 | 21 | -3 | N/A | -3 | N/A |
| 12/31/2013 | 20 | -3 | N/A | -3 | N/A |
| 9/30/2013 | 18 | -4 | N/A | -4 | N/A |
| 6/30/2013 | 15 | -6 | N/A | -5 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. tasa de ahorro: NAN(20.9% al año) es superior a la tasa de ahorro (2.2%).
Beneficios frente mercado: NANSe prevé que los beneficios de la empresa (20.9% al año) crezcan más deprisa que el mercado Australian (10% al año).
Beneficios de alto crecimiento: NANSe espera que los beneficios de la empresa crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: NANSe prevé que los ingresos de la empresa (9.3% al año) crezcan más deprisa que los del mercado Australian (4.2% al año).
Ingresos de alto crecimiento: NANSe prevé que los ingresos de la empresa (9.3% al año) crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
Futura rentabilidad financiera (ROE): NANSe prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (11%).